Why we need a small data paradigm
Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorou...
Uložené v:
| Vydané v: | BMC medicine Ročník 17; číslo 1; s. 133 - 9 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
17.07.2019
BioMed Central Ltd BMC |
| Predmet: | |
| ISSN: | 1741-7015, 1741-7015 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary ‘small data’ paradigm that can function both autonomously from and in collaboration with big data is also needed. By ‘small data’ we build on Estrin’s formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit.
Main body
The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.
Conclusion
Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. |
|---|---|
| AbstractList | Abstract Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary ‘small data’ paradigm that can function both autonomously from and in collaboration with big data is also needed. By ‘small data’ we build on Estrin’s formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. Main body The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. Conclusion Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary ‘small data’ paradigm that can function both autonomously from and in collaboration with big data is also needed. By ‘small data’ we build on Estrin’s formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. Main body The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. Conclusion Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit.BACKGROUNDThere is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit.The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.MAIN BODYThe purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved.CONCLUSIONSmall data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. Main body The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. Conclusion Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. Keywords: Precision medicine, Personalized medicine, Precision health, Small data, Artificial intelligence, Data science Background: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit.Main body: The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality.Conclusion: Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big data' efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary 'small data' paradigm that can function both autonomously from and in collaboration with big data is also needed. By 'small data' we build on Estrin's formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. |
| ArticleNumber | 133 |
| Audience | Academic |
| Author | Sim, Ida Hekler, Eric B. Lewis, Dana Chevance, Guillaume Golaszewski, Natalie M. Klasnja, Predrag |
| Author_xml | – sequence: 1 givenname: Eric B. surname: Hekler fullname: Hekler, Eric B. email: ehekler@eng.ucsd.edu organization: Center for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego – sequence: 2 givenname: Predrag surname: Klasnja fullname: Klasnja, Predrag organization: School of Information, University of Michigan – sequence: 3 givenname: Guillaume surname: Chevance fullname: Chevance, Guillaume organization: Center for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego – sequence: 4 givenname: Natalie M. surname: Golaszewski fullname: Golaszewski, Natalie M. organization: Center for Wireless & Population Health Systems, Department of Family Medicine and Public Health, Design Lab and Qualcomm Institute Faculty Member, UC San Diego – sequence: 5 givenname: Dana surname: Lewis fullname: Lewis, Dana organization: OpenAPS – sequence: 6 givenname: Ida surname: Sim fullname: Sim, Ida organization: School of Medicine, UC San Francisco |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31311528$$D View this record in MEDLINE/PubMed https://hal.science/hal-05040021$$DView record in HAL |
| BookMark | eNp9kl9rFDEUxQep2Hb1A_giI4Low9TcTP5MXgpLUVso-KL4GO5mkt0sM5M1ma3ttzfr1LJbpOQh4eZ3zs0N57Q4GsJgi-I1kDOARnxKQBWIioCqoBaiun1WnIBkUEkC_GjvfFycprQmhHIp2YviuIYagNPmpHj7c3VX_rblYG1bYpl67LqyxRHLDUZs_bJ_WTx32CX76n6fFT--fP5-cVldf_t6dTG_roxgZKyUJMw0gKxFpxgQVJI1ghthaG0Z1rK1quZIpKUU6cJRA8xBs1CNglpBU8-Kq8m3DbjWm-h7jHc6oNd_CyEuNcbRm85q3mIjiVNgHWecCWUUSO6EtC2tiXHZ63zy2mwXvW2NHcaI3YHp4c3gV3oZbrQQtSC0zgYfJ4PVI9nl_FrvaoQTlv8TbiCzH-6bxfBra9Ooe5-M7TocbNgmTSnPk3PeqIy-m9Al5jH84ELubna4nmeoyVB-waw4-w-VV2t7b3IEnM_1A8H7PcHKYjeuUui2ow9DOgTf7P_Lw2T_8pABmAATQ0rRugcEiN5lTk-Z0zlzepc5fZs18pHG-BF3vfOzffekkk7KlLsMSxv1OmzjkFP2hOgPQuHlKA |
| CitedBy_id | crossref_primary_10_1002_cpt_2511 crossref_primary_10_1016_j_procs_2024_08_024 crossref_primary_10_3389_fpubh_2024_1444521 crossref_primary_10_3390_nu15071756 crossref_primary_10_1016_j_indmarman_2022_08_014 crossref_primary_10_3389_fdgth_2022_945006 crossref_primary_10_1249_JES_0000000000000232 crossref_primary_10_3389_fpsyg_2025_1603474 crossref_primary_10_1093_tbm_ibaa026 crossref_primary_10_1038_s41592_024_02390_8 crossref_primary_10_3390_polym15010173 crossref_primary_10_1093_advances_nmab156 crossref_primary_10_1007_s13042_021_01487_2 crossref_primary_10_1016_j_jad_2025_119833 crossref_primary_10_1097_j_pain_0000000000003456 crossref_primary_10_1002_wcms_1701 crossref_primary_10_1136_bmjopen_2023_077219 crossref_primary_10_1002_med_21749 crossref_primary_10_1145_3381897 crossref_primary_10_3390_math12020237 crossref_primary_10_1177_17470161251351401 crossref_primary_10_1016_j_psyneuen_2023_106394 crossref_primary_10_1063_1_5117299 crossref_primary_10_1111_add_15687 crossref_primary_10_2196_52161 crossref_primary_10_1111_bdi_13340 crossref_primary_10_1186_s12888_024_05836_7 crossref_primary_10_1002_eat_24097 crossref_primary_10_1111_add_16173 crossref_primary_10_1016_j_procs_2021_03_075 crossref_primary_10_3390_diagnostics14192135 crossref_primary_10_1371_journal_pcbi_1009303 crossref_primary_10_3389_fcomp_2021_661890 crossref_primary_10_1017_S0954579423001281 crossref_primary_10_1002_lrh2_10419 crossref_primary_10_2196_41443 crossref_primary_10_2196_49208 crossref_primary_10_1007_s42979_020_0075_z crossref_primary_10_3390_bs11050077 crossref_primary_10_3390_sym13040612 crossref_primary_10_2196_25018 crossref_primary_10_1016_j_jad_2024_05_139 crossref_primary_10_1093_tbm_ibaa126 crossref_primary_10_1007_s11306_023_02067_x crossref_primary_10_3390_computation12100203 crossref_primary_10_1016_j_bspc_2025_107842 crossref_primary_10_3389_fdata_2020_00031 crossref_primary_10_1080_13607863_2025_2514066 crossref_primary_10_1088_1361_6560_ad0903 crossref_primary_10_1016_j_appet_2021_105440 crossref_primary_10_1093_abm_kaaa018 crossref_primary_10_1186_s12916_020_01841_1 crossref_primary_10_2196_28116 crossref_primary_10_3389_fdgth_2021_635524 crossref_primary_10_1002_lim2_55 crossref_primary_10_1080_1047840X_2020_1820214 crossref_primary_10_1186_s12916_019_1382_x crossref_primary_10_1007_s42438_024_00529_6 crossref_primary_10_1093_tbm_ibaa097 crossref_primary_10_3389_fdgth_2020_00002 crossref_primary_10_3389_fpsyg_2023_1143681 crossref_primary_10_1016_j_jbi_2024_104721 crossref_primary_10_1016_j_digbus_2025_100124 crossref_primary_10_1152_jn_00625_2020 crossref_primary_10_1093_tbm_ibab106 crossref_primary_10_1007_s41111_024_00255_1 crossref_primary_10_1016_j_procir_2024_08_009 crossref_primary_10_1080_21642850_2025_2552479 crossref_primary_10_3390_technologies12070112 crossref_primary_10_1016_j_indmarman_2024_12_014 crossref_primary_10_1016_j_engappai_2024_108288 crossref_primary_10_1177_00368504211029777 crossref_primary_10_3389_fnut_2020_00116 crossref_primary_10_3390_cancers15102705 crossref_primary_10_3389_fcomp_2020_636996 crossref_primary_10_1016_j_ins_2023_119078 crossref_primary_10_1016_j_procs_2024_08_007 crossref_primary_10_1007_s42212_020_00341_w crossref_primary_10_1136_jme_2023_109729 crossref_primary_10_1016_j_brs_2023_11_004 crossref_primary_10_3390_ijerph17020493 crossref_primary_10_1038_s44159_024_00369_y |
| Cites_doi | 10.2217/pme.11.7 10.1177/1932296818808307 10.1007/s11229-012-0225-5 10.1056/NEJMp1500523 10.2196/12910 10.1007/s13142-014-0258-z 10.1136/bmj.312.7023.71 10.1037/0003-066X.60.1.16 10.7551/mitpress/1092.001.0001 10.1145/3025453.3025480 10.1016/j.jbi.2018.01.010 10.1016/j.ecl.2016.04.008 10.1007/s13142-016-0395-7 10.1145/2984511.2984534 10.1145/2580944 10.1038/520609a 10.1037/hea0000242 10.1093/biomet/70.1.41 10.1111/j.1467-789X.2010.00740.x 10.1186/s13063-015-0590-8 10.1186/2001-1326-2-10 10.1001/jama.2016.3867 10.1001/jamainternmed.2018.3981 10.2196/jmir.2227 10.23919/ACC.2017.7962940 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2019 COPYRIGHT 2019 BioMed Central Ltd. licence_http://creativecommons.org/publicdomain/zero |
| Copyright_xml | – notice: The Author(s). 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: licence_http://creativecommons.org/publicdomain/zero |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC VOOES 5PM DOA |
| DOI | 10.1186/s12916-019-1366-x |
| DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (WRLC) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Computer Science |
| EISSN | 1741-7015 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_5da870f91ef545469c9175f67ed230cf PMC6636023 oai:HAL:hal-05040021v1 A593855866 31311528 10_1186_s12916_019_1366_x |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFFHD CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7X8 1XC VOOES 5PM |
| ID | FETCH-LOGICAL-c640t-9704c81a4daf9410a974865c6c23e4a37de935a07e22a2bf2c14f18b989139183 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 102 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000475774900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1741-7015 |
| IngestDate | Tue Oct 14 14:37:55 EDT 2025 Tue Nov 04 01:36:28 EST 2025 Tue Nov 25 06:21:19 EST 2025 Fri Sep 05 12:07:23 EDT 2025 Tue Nov 11 08:21:46 EST 2025 Tue Nov 04 17:08:47 EST 2025 Thu May 22 21:04:16 EDT 2025 Thu Jan 02 22:59:19 EST 2025 Sat Nov 29 04:08:18 EST 2025 Tue Nov 18 21:53:04 EST 2025 Sat Sep 06 07:29:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Small data Data science Precision medicine Personalized medicine Artificial intelligence Precision health |
| Language | English |
| License | licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c640t-9704c81a4daf9410a974865c6c23e4a37de935a07e22a2bf2c14f18b989139183 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-4570-703X 0000-0002-7434-0775 0000-0002-8926-4816 0000-0003-3524-0285 |
| OpenAccessLink | https://link.springer.com/10.1186/s12916-019-1366-x |
| PMID | 31311528 |
| PQID | 2259355589 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5da870f91ef545469c9175f67ed230cf pubmedcentral_primary_oai_pubmedcentral_nih_gov_6636023 hal_primary_oai_HAL_hal_05040021v1 proquest_miscellaneous_2259355589 gale_infotracmisc_A593855866 gale_infotracacademiconefile_A593855866 gale_healthsolutions_A593855866 pubmed_primary_31311528 crossref_primary_10_1186_s12916_019_1366_x crossref_citationtrail_10_1186_s12916_019_1366_x springer_journals_10_1186_s12916_019_1366_x |
| PublicationCentury | 2000 |
| PublicationDate | 2019-07-17 |
| PublicationDateYYYYMMDD | 2019-07-17 |
| PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-17 day: 17 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC medicine |
| PublicationTitleAbbrev | BMC Med |
| PublicationTitleAlternate | BMC Med |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | L Ljung (1366_CR28) 1999 NB Johnson (1366_CR10) 2014; 63 J Lee (1366_CR21) 2017 A Rozet (1366_CR35) 2019; 21 EO Lillie (1366_CR39) 2011; 8 RL Kravitz (1366_CR43) 2018; 178 1366_CR3 JE Staddon (1366_CR15) 2001 P Vandenbroeck (1366_CR7) 2010 WR Shadish (1366_CR23) 2002 WT Riley (1366_CR26) 2013; 2 RM Sapolsky (1366_CR13) 2017 SS Phatak (1366_CR20) 2019 M Polanyi (1366_CR32) 1958 R Kravitz (1366_CR37) 2014 1366_CR30 J Pearl (1366_CR22) 2018 FS Collins (1366_CR1) 2015; 372 1366_CR19 EB Hekler (1366_CR36) 2018 S Athey (1366_CR47) 2015; 1504 National Research Council (US) Committee on A Framework for Developing a New taxonomy of Disease (1366_CR4) 2011 EB Hekler (1366_CR16) 2016; 6 J Dallery (1366_CR41) 2013; 15 LW Green (1366_CR24) 1999 C Barr (1366_CR42) 2015; 16 DL Sackett (1366_CR2) 1996; 312 DR Williams (1366_CR12) 2016; 35 NJ Schork (1366_CR38) 2015; 520 EB Hekler (1366_CR34) 2019 A Smedley (1366_CR11) 2005; 60 EB Hekler (1366_CR27) 2018; 20 J Dallery (1366_CR40) 2014; 4 EJ Daza (1366_CR46) 2018; 57 R Karkar (1366_CR18) 2017; 2017 AR Damasio (1366_CR33) 2006 NN Taleb (1366_CR17) 2007 DA Chambers (1366_CR25) 2016; 315 JCM Barte (1366_CR9) 2010; 11 WW Fisher (1366_CR14) 2011 B Miller (1366_CR44) 2013; 190 N Alamuddin (1366_CR8) 2016; 45 S Phatak (1366_CR29) 2018; 79 PR Rosenbaum (1366_CR45) 1983; 70 The Precision Medicine Advisory Committee (1366_CR5) 2018 Dana Lewis (1366_CR31) 2018; 13 D Estrin (1366_CR6) 2014; 57 |
| References_xml | – volume: 8 start-page: 161 issue: 2 year: 2011 ident: 1366_CR39 publication-title: Personalized Med doi: 10.2217/pme.11.7 – ident: 1366_CR3 – volume-title: Does It Work For Me? Supporting Self-Experimentation of Simple Health Behavior Interventions. Dissertation Arizona State University year: 2019 ident: 1366_CR20 – volume-title: Precision Medicine: An Action Plan for California year: 2018 ident: 1366_CR5 – volume: 13 start-page: 790 issue: 4 year: 2018 ident: 1366_CR31 publication-title: Journal of Diabetes Science and Technology doi: 10.1177/1932296818808307 – volume: 190 start-page: 1293 issue: 7 year: 2013 ident: 1366_CR44 publication-title: Synthese. doi: 10.1007/s11229-012-0225-5 – volume-title: System identification: theory for the user year: 1999 ident: 1366_CR28 – volume-title: The individual evidence pyramid year: 2018 ident: 1366_CR36 – volume: 372 start-page: 793 issue: 9 year: 2015 ident: 1366_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMp1500523 – volume-title: The black swan: the impact of the highly improbable year: 2007 ident: 1366_CR17 – volume-title: Experimental and quasi-experimental designs for generalized causal inference year: 2002 ident: 1366_CR23 – volume: 21 start-page: e12910 issue: 4 year: 2019 ident: 1366_CR35 publication-title: J Med Internet Res doi: 10.2196/12910 – volume: 20 start-page: e214 issue: 6 year: 2018 ident: 1366_CR27 publication-title: J Med Int Res – volume: 4 start-page: 290 issue: 3 year: 2014 ident: 1366_CR40 publication-title: Transl Behav Med doi: 10.1007/s13142-014-0258-z – volume: 57 start-page: e10 issue: 01 year: 2018 ident: 1366_CR46 publication-title: Methods Inf Med – volume: 312 start-page: 71 issue: 7023 year: 1996 ident: 1366_CR2 publication-title: BMJ. doi: 10.1136/bmj.312.7023.71 – volume-title: Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease year: 2011 ident: 1366_CR4 – volume: 60 start-page: 16 issue: 1 year: 2005 ident: 1366_CR11 publication-title: Am Psychol doi: 10.1037/0003-066X.60.1.16 – volume-title: Adaptive dynamics: the theoretical analysis of behavior year: 2001 ident: 1366_CR15 doi: 10.7551/mitpress/1092.001.0001 – volume: 2017 start-page: 6850 year: 2017 ident: 1366_CR18 publication-title: Proc SIGCHI Conf Hum Factor Comput Syst doi: 10.1145/3025453.3025480 – volume-title: Personal knowledge: towards a post-critical philosophy year: 1958 ident: 1366_CR32 – volume: 79 start-page: 82 year: 2018 ident: 1366_CR29 publication-title: J Biomed Inform doi: 10.1016/j.jbi.2018.01.010 – volume: 45 start-page: 565 issue: 3 year: 2016 ident: 1366_CR8 publication-title: Endocrinol Metabol Clin doi: 10.1016/j.ecl.2016.04.008 – volume: 6 start-page: 317 issue: 2 year: 2016 ident: 1366_CR16 publication-title: Transl Behav Med doi: 10.1007/s13142-016-0395-7 – ident: 1366_CR19 doi: 10.1145/2984511.2984534 – volume-title: Community and population health year: 1999 ident: 1366_CR24 – volume: 57 start-page: 32 issue: 4 year: 2014 ident: 1366_CR6 publication-title: Commun ACM doi: 10.1145/2580944 – volume: 520 start-page: 609 issue: 7549 year: 2015 ident: 1366_CR38 publication-title: Nature. doi: 10.1038/520609a – volume-title: and Implementation of N-of-1 Trials: A User’s Guide year: 2014 ident: 1366_CR37 – volume: 63 start-page: 3 issue: 4 year: 2014 ident: 1366_CR10 publication-title: MMWR Suppl – volume: 35 start-page: 407 issue: 4 year: 2016 ident: 1366_CR12 publication-title: Health Psychol doi: 10.1037/hea0000242 – volume-title: Lived experience and scientific consensus year: 2019 ident: 1366_CR34 – volume-title: Handbook of applied behavior analysis year: 2011 ident: 1366_CR14 – volume-title: Tackling obesities: future choices – obesity system atlas year: 2010 ident: 1366_CR7 – volume-title: The book of why: the new science of cause and effect year: 2018 ident: 1366_CR22 – volume-title: Descartes’ Error year: 2006 ident: 1366_CR33 – volume: 1504 start-page: 01132v3 year: 2015 ident: 1366_CR47 publication-title: arXiv – volume: 70 start-page: 41 issue: 1 year: 1983 ident: 1366_CR45 publication-title: Biometrika. doi: 10.1093/biomet/70.1.41 – volume: 11 start-page: 899 issue: 12 year: 2010 ident: 1366_CR9 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2010.00740.x – volume-title: Behave: the biology of humans at our best and worst year: 2017 ident: 1366_CR13 – volume: 16 start-page: 67 year: 2015 ident: 1366_CR42 publication-title: Trials. doi: 10.1186/s13063-015-0590-8 – volume: 2 start-page: 1 issue: 1 year: 2013 ident: 1366_CR26 publication-title: Clin Transl Med doi: 10.1186/2001-1326-2-10 – start-page: 6837 volume-title: Self-experimentation for behavior change: design and formative evaluation of two approaches. CHI '17. Proceedings of the 2017 CHI conference on human factors in computing systems year: 2017 ident: 1366_CR21 – volume: 315 start-page: 1941 issue: 18 year: 2016 ident: 1366_CR25 publication-title: JAMA. doi: 10.1001/jama.2016.3867 – volume: 178 start-page: 1368 issue: 10 year: 2018 ident: 1366_CR43 publication-title: JAMA Inter Med doi: 10.1001/jamainternmed.2018.3981 – volume: 15 start-page: e22 issue: 2 year: 2013 ident: 1366_CR41 publication-title: J Med Internet Res doi: 10.2196/jmir.2227 – ident: 1366_CR30 doi: 10.23919/ACC.2017.7962940 |
| SSID | ssj0025774 |
| Score | 2.5800261 |
| Snippet | Background
There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via... There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various 'big... Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via... Background: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via... Abstract Background There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision... |
| SourceID | doaj pubmedcentral hal proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 133 |
| SubjectTerms | Analysis Artificial intelligence Beyond Big Data to new Biomedical and Health Data Science: moving to next century precision health Big data Biomedicine Cellular proteins Chronic diseases Computer Science Cooperative Behavior Data Interpretation, Statistical Data science Data Science - methods Data Science - trends Datasets as Topic - standards Datasets as Topic - statistics & numerical data Datasets as Topic - supply & distribution Debate Delivery of Health Care - methods Delivery of Health Care - statistics & numerical data Ecology, environment Electronic records Emerging Technologies Evidence-based medicine Health Health care reform High-Throughput Screening Assays - methods High-Throughput Screening Assays - statistics & numerical data Humans Learning Life Sciences Management Medical informatics Medical records Medicine Medicine & Public Health Personalized medicine Precision health Precision medicine Precision Medicine - methods Precision Medicine - statistics & numerical data Santé publique et épidémiologie Small data Small-Area Analysis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLagQogLYidQIEVISKCo8RIvxwFR9VAqDiB6szxeOiNNU9RMS_n3vOdkIkIFXLgmL4s_v1V-_kzIKyHqOeWBVVSnWAlKQ6Ul95VjJnhMcKPLJK4H6vBQHx2ZT78c9YU9YT09cA_cbhMcqFQyNCYI9lDMeSgwmiRVDJA9-4TeF7KeTTE1lFoNZDXDGibVcreDqEaxcjYV5VJWl5MolMn6R5d8fYEdkVfTzatdk78tneaItHeH3B5SyXLWD-EuuRbbe-Tmx2Gx_D7Z-br4UX6PZQsBqnRld-JWqxI7Qkvk-w7L45MH5Mveh8_v96vhRITKS1GvK6Nq4TV1IrhkBK0dVANaNl56xqNwXIVoeONqFRlzbJ6YpyJRPTe4GGnAeh-Srfa0jY9JqTSP0hkIUMELJaDw4UYaV6dk5kHVsiD1BiHrB7pwPLViZXPZoKXtQbUAqkVQ7WVB3oyPfOu5Mv4m_A5hHwWR5jpfgMm3w-Tbf01-QV7gpNl-z-horHbWGK6bRksYxussgeYKv-_dsOsAQEDiq4nk9kQSzMxPbr8ExZj87v7swOK1ukFPyOgFLcjORm8sPo8NbG08Pe8suE1ksm-0KcijXo_Gd_FMecR0QdREwyYfm95pl4tMBS6R7o3xgrzd6KIdfFD3Z-if_A_on5JbrM4b4CqqtsnW-uw8PiM3_MV62Z09z9b4EzSTMY8 priority: 102 providerName: Directory of Open Access Journals |
| Title | Why we need a small data paradigm |
| URI | https://link.springer.com/article/10.1186/s12916-019-1366-x https://www.ncbi.nlm.nih.gov/pubmed/31311528 https://www.proquest.com/docview/2259355589 https://hal.science/hal-05040021 https://pubmed.ncbi.nlm.nih.gov/PMC6636023 https://doaj.org/article/5da870f91ef545469c9175f67ed230cf |
| Volume | 17 |
| WOSCitedRecordID | wos000475774900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals (WRLC) customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB5sK-KLd220rqkIgiWYuWQuj1tpqdAuS72tT8PsZNJd2GbLZlv133tmcoFYFfQlkORMkjM515wzXxB6xVg6xTQnCZaFSxjGeSI5tYkhKrc-wHUmgLgei9FITiZq3Kzjrtpu97YkGSx1UGvJ31bgmbDPflWCKecJBI5b4O2k18bTD5-7LCuDgKYpX_52WM8BBZz-zhpvzHwz5PVI83rD5C9V0-CMDu_-Fxv30J0m9oyHtbDcRzdc-QDdOmmq6w_R7pfZj_ibi0vwaLGJq3OzWMS-hTT2AOH5_Oz8Efp0ePDx3VHS_EIhsZyl60SJlFmJDctNoRhODaQPkmeWW0IdM1TkTtHMpMIRYsi0IBazAsup8tVLBer-GG2Wy9Jto1hI6rhR4NFyywSDTIkqrkxaFGqai5RHKG3nVdsGX9z_5mKhQ54hua5Z18C69qzr7xF60w25qME1_ka8719WR-hxscOB5epMN2qms9yAASoUdgWEhpD6W0hHs4ILl0OuZYsIvfCvWteLTDvt1sNMUZllkgMbrwOF1294fGuaZQowCR4pq0e506MEvbS90y9BnHqPezQ81v5YmnnTSfAVjtBuK23aj_cdb6VbXlYa7KyHvs-kitCTWvq6a9GAkURkhERPLns3658p57OAHc49PhyhEdprpVM3Rqv689Q__SfqZ-g2ScPSuASLHbS5Xl265-imvVrPq9UAbYiJCFs5QFv7B6Px6SB8CIG98fuT8ddBUOefZqE8Lw |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagIOCF-wgUmiIkpKIIX3HsxwVRLWK7QlCgb5bXdrorbbNosy3w7xk7hxQKSPAaj5OMPadm_BmhZ5zjGWGOZkSWPuOEuEwKZjNDlbMhwPUmgrhOiulUHh2p9-057rrrdu9KktFSR7WW4mUNnomE7FdlhAmRQeB4iYPDCn18Hz5-7rOsHAKatnz522kDBxRx-ntrfHEemiHPR5rnGyZ_qZpGZ7R_47_YuImut7FnOmqE5Ra64Kvb6MpBW12_g3a_zH-k33xagUdLTVqfmOUyDS2kaQAId4vjk7vo0_6bw9fjrL1CIbOC402mCsytJIY7UypOsIH0QYrcCkuZ54YVziuWG1x4Sg2dldQSXhI5U6F6qUDd76GtalX5BygtJPPCKPBozvKCQ6bElFAGl6WauQKLBOFuXbVt8cXDNRdLHfMMKXTDugbWdWBdf0_QXj_lawOu8TfiV2GzesKAix0frNbHulUznTsDBqhUxJcQGkLqbyEdzUtReAe5li0TtBO2WjeHTHvt1qNcMZnnUgAbzyNF0G_4fWvaYwqwCAEpa0C5PaAEvbSD4acgToPfHY8mOjzDeTCdlJyRBO120qbD_NDxVvnVaa3Bzgbo-1yqBN1vpK9_F4sYSVQmqBjI5eBjw5FqMY_Y4SLgw1GWoBeddOrWaNV_XvqH_0S9g66ODw8mevJ2-u4RukZxPCaXkWIbbW3Wp_4xumzPNot6_SQq7k9k8TkD |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagoIoX7iNQaIqQkEBW4yOO_bgcqyKWVSWuvlleH92Vttlqsy3w7_HkkkIBCfHqjBOPM6dm_BmhZ5xnM8IcxUQGjzkhDkvBLDZUOQsBrjc1iOukmE7l0ZE6bO85rbpu964k2ZxpAJSmcrN_6kKj4lLsV9FLEciEFSZMCByDyCsc7gyCdP3jlz7jymNw05Yyfztt4IxqzP7eMl-eQ2PkxajzYvPkLxXU2jGNb_w3SzfR9TYmTUeNEN1Cl3x5G21_aKvud9De1_mP9JtPy-jpUpNWJ2a5TKG1NAXgcLc4PrmLPo_ffnp9gNurFbAVPNtgVWTcSmK4M0HFnTMxrZAit8JS5rlhhfOK5SYrPKWGzgK1hAciZwqqmiqagXtoq1yV_gFKC8m8MCp6Omd5wWMGxZRQJgtBzVyRiQRl3R5r2-KOw_UXS13nH1LohnUdWdfAuv6eoBf9lNMGdONvxK_gx_WEgJddD6zWx7pVP507Ew1TUMSHGDJyoWxMU_MgCu9iDmZDgnbht-vm8Gmv9XqUKybzXIrIxvOaAvQ-Lt-a9vhC3ARA0BpQ7gwoo77aweOnUbQGyz0YTTSMZTmYVErOSYL2OsnTMB864Uq_Oqt0tL8AiZ9LlaD7jST272I1dhKVCSoGMjr42PBJuZjXmOICcOMoS9DLTlJ1a8yqP2_9w3-i3kXbh2_GevJu-v4Rukaz-vQcJsUO2tqsz_xjdNWebxbV-kmtwz8BQ8pB5w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Why+we+need+a+small+data+paradigm&rft.jtitle=BMC+medicine&rft.au=Hekler%2C+Eric+B.&rft.au=Klasnja%2C+Predrag&rft.au=Chevance%2C+Guillaume&rft.au=Golaszewski%2C+Natalie+M.&rft.date=2019-07-17&rft.pub=BioMed+Central&rft.eissn=1741-7015&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12916-019-1366-x&rft.externalDocID=10_1186_s12916_019_1366_x |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon |